These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 1981553)
1. In vivo interaction of cabergoline with rat brain dopamine receptors labelled with [3H]N-n-propylnorapomorphine. Benedetti MS; Dostert P; Barone D; Efthymiopoulos C; Peretti G; Roncucci R Eur J Pharmacol; 1990 Oct; 187(3):399-408. PubMed ID: 1981553 [TBL] [Abstract][Full Text] [Related]
2. Characterization of normal and supersensitive dopamine receptors: effects of ergot drugs and neuropeptides. Fuxe K; Agnati LF; Köhler C; Kuonen D; Ogren SO; Andersson K; Hökfelt T J Neural Transm; 1981; 51(1-2):3-37. PubMed ID: 7264628 [TBL] [Abstract][Full Text] [Related]
3. Dopamine receptor affinities in vitro and stereotypic activities in vivo of cabergoline in rats. Miyagi M; Itoh F; Taya F; Arai N; Isaji M; Kojima M; Ujiie A Biol Pharm Bull; 1996 Sep; 19(9):1210-3. PubMed ID: 8889042 [TBL] [Abstract][Full Text] [Related]
4. Irreversible receptor inactivation reveals differences in dopamine receptor reserve between A9 and A10 dopamine systems: an electrophysiological analysis. Cox RF; Waszczak BL Brain Res; 1990 Nov; 534(1-2):273-82. PubMed ID: 1981482 [TBL] [Abstract][Full Text] [Related]
5. Differences in dopamine receptor reserve for N-n-propylnorapomorphine enantiomers: single unit recording studies after partial inactivation of receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline. Cox RF; Waszczak BL Mol Pharmacol; 1989 Jan; 35(1):125-31. PubMed ID: 2563304 [TBL] [Abstract][Full Text] [Related]
6. Regional in vivo binding of [3H]N-propylnorapomorphine in the mouse brain. Evidence for labelling of central dopamine receptors. Köhler C; Fuxe K; Ross SB Eur J Pharmacol; 1981 Jul; 72(4):397-402. PubMed ID: 7274333 [TBL] [Abstract][Full Text] [Related]
7. Characterization of [3H]quinpirole binding to D2-like dopamine receptors in rat brain. Levant B; Grigoriadis DE; DeSouza EB J Pharmacol Exp Ther; 1992 Sep; 262(3):929-35. PubMed ID: 1356154 [TBL] [Abstract][Full Text] [Related]
8. R(-)2-fluoro-N-n-propylnorapomorphine: a very potent and D2-selective dopamine agonist. Baldessarini RJ; Kula NS; Gao Y; Campbell A; Neumeyer JL Neuropharmacology; 1991 Jan; 30(1):97-9. PubMed ID: 1675452 [TBL] [Abstract][Full Text] [Related]
9. In vivo binding of N-n-propylnorapomorphine in the rat brain: regional localization, quantification in striatum and lack of correlation with dopamine metabolism. van der Werf JF; Sebens JB; Vaalburg W; Korf J Eur J Pharmacol; 1983 Feb; 87(2-3):259-70. PubMed ID: 6404643 [TBL] [Abstract][Full Text] [Related]
10. Autoradiographic localization and quantification of dopamine D2 receptors in normal human brain with [3H]N-n-propylnorapomorphine. Camus A; Javoy-Agid F; Dubois A; Scatton B Brain Res; 1986 Jun; 375(1):135-49. PubMed ID: 3719352 [TBL] [Abstract][Full Text] [Related]
11. ACTH/MSH-like peptides inhibit the binding of dopaminergic ligands to the dopamine D2 receptor in vitro. Florijn WJ; De Boer T; Tonnaer JA; Van Nispen JW; Versteeg DH Eur J Pharmacol; 1991 May; 207(1):43-50. PubMed ID: 1680721 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of substantia nigra dopamine cell firing by R(-)-N-n-propylnorapomorphine: electrophysiological and autoradiographic studies after regional inactivation of dopamine receptors by microinjection of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline. Cox RF; Waszczak BL Brain Res; 1993 Jun; 613(1):32-42. PubMed ID: 8102308 [TBL] [Abstract][Full Text] [Related]
13. Heterogeneous distribution of dopamine D2 receptors within the rat striatum as revealed by autoradiography of [3H]N-n-propylnorapomorphine binding sites. Dubois A; Scatton B Neurosci Lett; 1985 Jun; 57(1):7-12. PubMed ID: 3162114 [TBL] [Abstract][Full Text] [Related]
14. Kinetic properties of the in vivo accumulation of 3H-(-)-N-n-propylnorapomorphine in mouse brain. Ross SB; Jackson DM Naunyn Schmiedebergs Arch Pharmacol; 1989 Jul; 340(1):13-20. PubMed ID: 2571943 [TBL] [Abstract][Full Text] [Related]
15. The role of multiple dopamine receptors in apomorphine and N-n-propylnorapomorphine-induced climbing and hypothermia. Moore NA; Axton MS Eur J Pharmacol; 1990 Mar; 178(2):195-201. PubMed ID: 2184043 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the dopaminergic effects of apomorphine and (-)-N-n-propylnorapomorphine. Menon MK; Clark WG; Neumeyer JL Eur J Pharmacol; 1978 Nov; 52(1):1-9. PubMed ID: 569056 [TBL] [Abstract][Full Text] [Related]
17. Effect of chronic treatment with morphine on the binding of 3H-N-n-propylnorapomorphine to striatal membranes of rats: influence of prolyl-leucyl-glycinamide. Das S; Bhargava HN Pharmacology; 1985; 31(5):241-7. PubMed ID: 2866551 [TBL] [Abstract][Full Text] [Related]
18. Inactivation of dopamine D-1 or D-2 receptors differentially inhibits stereotypies induced by dopamine agonists in rats. Arnt J; Hyttel J; Meier E Eur J Pharmacol; 1988 Oct; 155(1-2):37-47. PubMed ID: 2907491 [TBL] [Abstract][Full Text] [Related]
19. Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines. Booth RG; Baldessarini RJ; Kula NS; Gao Y; Zong R; Neumeyer JL Mol Pharmacol; 1990 Jul; 38(1):92-101. PubMed ID: 1973525 [TBL] [Abstract][Full Text] [Related]
20. Effects of N-n-propylnorapomorphine enantiomers on single unit activity of substantia nigra pars compacta and ventral tegmental area dopamine neurons. Cox RF; Neumeyer JL; Waszczak BL J Pharmacol Exp Ther; 1988 Oct; 247(1):355-62. PubMed ID: 3171980 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]